Human umbilical cord plasma concentrate

Human umbilical cord plasma concentrate has been studied in 1 paper since 2022: 1 trial in people. The newest paper, Sep 2, 2022: “Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers”.

Intervention

1 paper studies it7 findingsUpdated

See all 1 papers on human umbilical cord plasma concentrate

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“AgeAccelGrim was significantly decreased from 0.04 to −0.78 (paired Student's t‐test p = 9.3E‐3).”
Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkersAging cell2022doi:10.1111/acel.13696

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: National Institute on Aging
  • 7 of 7 findings with company ties
  • Human trial1

Studies in people

1 study gave human umbilical cord plasma concentrate to people and measured what changed.

What changedDesignPeopleSource

down: Decreases GrimAgefrom 0.04 to −0.78

down: Decreases creatinine

up: Increases estimated glomerular filtration rate

Trial10 weeks18 people10 women and 8 menaverage age of 74 (range 60 to 95)Older adults considered to be in normal health for their agesAging cell, Sep 2, 2022

What did studies of human umbilical cord plasma concentrate find?

6

Studies of human umbilical cord plasma concentrate measured 6 outcomes, among them GrimAge, telomere length and epigenetic clocks estimating chronological age.

GrimAge

downin humans1

1 study
  1. Human umbilical cord plasma concentrate decreases GrimAge in humans (-0.82 years).

    “The treatment reduced DNA methylation-based GrimAge by an average of 0.82 years (p = 0.0093)”

    Human trial1 ml intramuscular weekly10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

  2. Human umbilical cord plasma concentrate decreases GrimAge in humans (from 0.04 to −0.78).

    “AgeAccelGrim was significantly decreased from 0.04 to −0.78 (paired Student's t‐test p = 9.3E‐3).”

    Human trial10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on GrimAge

Telomere length

no changein humans1

1 study
  1. Human umbilical cord plasma concentrate showed no clear effect on telomere length in humans.

    “telomere length and mtDNA-CN were not significantly affected by the treatment”

    Human trial1 ml intramuscular weekly10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on Telomere length

Epigenetic clocks estimating chronological age

no changein humans1

1 study
  1. Human umbilical cord plasma concentrate showed no clear effect on epigenetic clocks estimating chronological age in humans.

    “By contrast, no significant results could be observed for epigenetic clocks that estimate chronological age.”

    Human trial1 ml intramuscular weekly10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on Epigenetic clocks estimating chronological age

Immunoglobulins

downin humans1

1 study
  1. Human umbilical cord plasma concentrate decreases immunoglobulins in humans.

    “Three of four immunoglobulin biomarkers decreased”

    Human trial1 ml intramuscular weekly10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on Immunoglobulins

Estimated glomerular filtration rate

upin humans1

1 study
  1. Human umbilical cord plasma concentrate increases estimated glomerular filtration rate in humans.

    “estimated glomerular filtration rate (eGFR) was increased (p = 0.0044)”

    Human trial1 ml intramuscular weekly10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on Estimated glomerular filtration rate

Creatinine

downin humans1

1 study
  1. Human umbilical cord plasma concentrate decreases creatinine in humans.

    “Specifically, creatinine level decreased after the treatment (p = 3.9E‐3) and eGFR values increased (p = 4.4E‐3).”

    Human trial10 weeksn = 18

    Umbilical cord plasma concentrate has beneficial effects on DNA methylation GrimAge and human clinical biomarkers

    Aging cell

More on Creatinine

Latest